Arif A Khan Selected Research

Vaccines

1/2018	Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107+ CD8+ T Cells That Infiltrate the Corneas and Trigeminal Ganglia of Humanized HLA Transgenic Rabbits and Protect against Ocular Herpes Challenge.
1/2017	Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
7/2015	Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
6/2015	A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arif A Khan Research Topics

Disease

8	Infections 01/2018 - 05/2013
3	Herpesviridae Infections (Herpesvirus Infection) 01/2018 - 01/2017
2	Herpes Simplex 01/2017 - 07/2015
1	Herpes Genitalis (Genital Herpes) 01/2018
1	Inflammation (Inflammations) 02/2017
1	Muscular Diseases (Myopathy) 02/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2017
1	Eye Infections 01/2016
1	Corneal Injuries 01/2016
1	Herpetic Keratitis 06/2015
1	Pancreatitis 10/2002

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2018 - 06/2015
4	HLA-A Antigens (HLA-A)IBA 01/2017 - 11/2013
4	EpitopesIBA 01/2017 - 11/2013
2	ChemokinesIBA 01/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 02/2017 - 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 02/2017
1	NLR ProteinsIBA 02/2017
1	Valosin Containing ProteinIBA 02/2017
1	Caspase 1 (ICE Protease)IBA 02/2017
1	Interleukin-18 (Interleukin 18)IBA 02/2017
1	InflammasomesIBA 02/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017
1	Chemokine CXCL10IBA 01/2017
1	Neutralizing AntibodiesIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 04/2015
1	Simplexvirus glycoprotein BIBA 11/2013
1	MicroRNAs (MicroRNA)IBA 05/2013
1	AntigensIBA 05/2013

Therapy/Procedure

1	Length of Stay 10/2002